ArticleScientific reports2026
Sleep quality and quality of life in patients with dermatological diseases during the war in Gaza.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin diseases such as psoriasis and scabies can severely impact sleep quality and quality of life (QoL), especially under extreme stress conditions such as war. During the 2024 conflict in Gaza, displacement, limited access to healthcare, and widespread trauma created a unique context in which to study these interactions. This cross-sectional study included 498 participants from three healthcare centers across Gaza. Data on dermatological diagnoses, sleep quality (PSQI), quality of life (DLQI/CDLQI), pain levels, and displacement history were collected. Statistical analyses were performed to explore correlations and significant predictors of sleep and QoL outcomes. Poor sleep and reduced QoL were significantly associated with psoriasis, scabies, frequent displacement, high pain levels, and unemployment. Adults with psoriasis had the highest DLQI scores (mean = 15.82), whereas children with psoriasis and scabies had scores of 9.25 and 8.22, respectively, on the CDLQI. Sleep was worst among those with scabies (mean PSQI = 15.88). Displacement frequency was a key predictor; those displaced 10 or more times had notably higher impairment scores. Employment status, residency status (especially in Gaza City), and pain level were also significant. No substantial differences were found by sex, marital status, or education. Warm intensified the burden of skin diseases on both sleep quality and QoL. Displacement, pain, and socioeconomic hardship are key drivers of poor outcomes. Children and unemployed individuals are particularly vulnerable. These findings call for trauma-informed, integrated care approaches that combine dermatological treatment, mental health support, and social services, particularly for displaced and high-risk groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.